Patients with diabetes as the primary kidney disease have a worse survival than patients with comorbid diabetes in chronic haemodialysis patients

Nephrology

Volumn 20, Issue 3, 2015, Pages 155-160

  Chen, Hung Chih ^a   Chou, Che Yi ^a,b   Hsiao, Yi Tzone ^c   Liang, Chih Chia ^a,b   Kuo, Huey Liang ^a,b   Chang, Chiz Tzung ^a,b   Liu, Jiung Hsiun ^a,b   Wang, I Kuan ^a,b   Huang, Chiu Ching ^a,b  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

comorbidity; diabetic kidney disease; fasting blood glucose; haemodialysis; mortality

Indexed keywords

GLUCOSE; PHOSPHATE;

ARTICLE; COMORBIDITY; DIABETES MELLITUS; GENDER; GLUCOSE BLOOD LEVEL; HEMATOCRIT; HEMODIALYSIS; HEMODIALYSIS PATIENT; KIDNEY DISEASE; LIVER CIRRHOSIS; MORTALITY; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; SURVIVAL; TAIWAN; ADVERSE EFFECTS; AGED; COMPARATIVE STUDY; DIABETIC NEPHROPATHIES; EPIDEMIOLOGY; FEMALE; HUMAN; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; REGISTER; RENAL INSUFFICIENCY, CHRONIC; RENAL REPLACEMENT THERAPY; RISK FACTOR; STATISTICAL MODEL; TIME; TREATMENT OUTCOME;

AGED; COMORBIDITY; DIABETES MELLITUS; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REGISTRIES; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; TAIWAN; TIME FACTORS; TREATMENT OUTCOME;

EID: 84923326622     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/nep.12376     Document Type: Article

References (34)

1. Brancati FL, Whelton PK, Randall BL, Neaton JD, Stamler J, Klag MJ,. Risk of end-stage renal disease in diabetes mellitus: A prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial. JAMA 1997; 278: 2069-2074.
2. New chapter on CKD highlights changes to 15th annual USRDS report. Nephrol. News Issues 2003; 17: 25-28, 110.
3. Lok CE, Oliver MJ, Rothwell DM, Hux JE,. The growing volume of diabetes-related dialysis: A population based study. Nephrol. Dial. Transplant. 2004; 19: 3098-3103.
4. Van Dijk PC, Jager KJ, Stengel B, Gronhagen-Riska C, Feest TG, Briggs JD,. Renal replacement therapy for diabetic end-stage renal disease: Data from 10 registries in Europe (1991-2000). Kidney Int. 2005; 67: 1489-1499.
5. Shaw JE, Sicree RA, Zimmet PZ,. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res. Clin. Pract. 2010; 87: 4-14.
6. Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF,. Projection of the year 2050 burden of diabetes in the US adult population: Dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul. Health Metr. 2010; 8: 29.
7. Magliano DJ, Soderberg S, Zimmet PZ, et al. Mortality, all-cause and cardiovascular disease, over 15 years in multiethnic mauritius: Impact of diabetes and intermediate forms of glucose tolerance. Diabetes Care 2010; 33: 1983-1989.
8. Barr EL, Zimmet PZ, Welborn TA, et al. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: The Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation 2007; 116: 151-157.
9. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am. J. Kidney Dis. 2005; 45: S1-153.
10. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26 (Suppl 1): S5-20.
11. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O,. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N. Engl. J. Med. 2003; 348: 383-393.
12. Genuth S, Alberti KG, Bennett P, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 3160-3167.
13. Selby JV, FitzSimmons SC, Newman JM, Katz PP, Sepe S, Showstack J,. The natural history and epidemiology of diabetic nephropathy. Implications for prevention and control. JAMA 1990; 263: 1954-1960.
14. Rigalleau V, Garcia M, Lasseur C, et al. Large kidneys predict poor renal outcome in subjects with diabetes and chronic kidney disease. BMC Nephrol. 2010; 11: 3.
15. Schroijen MA, Dekkers OM, Grootendorst DC, et al. Survival in dialysis patients is not different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition. BMC Nephrol. 2011; 12: 69.
16. McFarlane SI, McCullough PA, Sowers JR, et al. Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: Prevalence of and risk factors for diabetes mellitus in CKD in the Kidney Early Evaluation Program (KEEP). Am. J. Kidney Dis. 2011; 57: S24-31.
17. Chou CY, Liang CC, Kuo HL, et al. Comparing risk of new onset diabetes mellitus in chronic kidney disease patients receiving peritoneal dialysis and hemodialysis using propensity score matching. PLoS One 2014; 9: e87891.
18. Schroijen MA, van de Luijtgaarden MW, Noordzij M, et al. Survival in dialysis patients is different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition. Diabetologia 2013; 56: 1949-1957.
19. Dormandy JA, Charbonnel B, Eckland DJ, et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): A randomised controlled trial. Lancet 2005; 366: 1279-1289.
20. Gottlieb DJ, Punjabi NM, Newman AB, et al. Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch. Intern. Med. 2005; 165: 863-867.
21. Lavie P, Herer P, Hoffstein V,. Obstructive sleep apnoea syndrome as a risk factor for hypertension: Population study. BMJ 2000; 320: 479-482.
22. Wei M, Gaskill SP, Haffner SM, Stern MP,. Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study. Diabetes Care 1998; 21: 1167-1172.
23. Glucose tolerance and cardiovascular mortality: Comparison of fasting and 2-hour diagnostic criteria. Arch. Intern. Med. 2001; 161: 397-405.
24. Villar E, Chang SH, McDonald SP,. Incidences, treatments, outcomes, and sex effect on survival in patients with end-stage renal disease by diabetes status in Australia and New Zealand (1991 2005). Diabetes Care 2007; 30: 3070-3076.
25. Belch J, MacCuish A, Campbell I, et al. The prevention of progression of arterial disease and diabetes (POPADAD) trial: Factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. BMJ 2008; 337: a1840.
26. Dalrymple LS, Johansen KL, Chertow GM, et al. Infection-related hospitalizations in older patients with ESRD. Am. J. Kidney Dis. 2010; 56: 522-530.
27. Lin EH, Rutter CM, Katon W, et al. Depression and advanced complications of diabetes: A prospective cohort study. Diabetes Care 2010; 33: 264-269.
28. Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann. Intern. Med. 2003; 139: 137-147.
29. Walker PD, Cavallo T, Bonsib SM,. Practice guidelines for the renal biopsy. Mod. Pathol. 2004; 17: 1555-1563.
30. Williams ME, Lacson E Jr, Teng M, Ofsthun N, Lazarus JM,. Hemodialyzed type I and type II diabetic patients in the US: Characteristics, glycemic control, and survival. Kidney Int. 2006; 70: 1503-1509.
31. Snit M, Dwornicki M, Zukowska-Szczechowska E, Grzeszczak W,. Impact of glycemic control on survival of diabetic patients on chronic regular hemodialysis: A 7-year observational study. Diabetes Care 2007; 30: 189; author reply 189-90.
32. Cefalu WT, Watson K,. Intensive glycemic control and cardiovascular disease observations from the ACCORD study: Now what can a clinician possibly think? Diabetes 2008; 57: 1163-1165.
33. Ishimura E, Okuno S, Kono K, et al. Glycemic control and survival of diabetic hemodialysis patients-importance of lower hemoglobin A1C levels. Diabetes Res. Clin. Pract. 2009; 83: 320-326.
34. Zager PG, Nikolic J, Brown RH, et al. 'U' curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc. Kidney Int. 1998; 54: 561-569.